INCY Incyte Corporation

INCY Incyte Corporation

Healthcare · Biotechnology

Market read

Scan convergence 2 scans as of 2026-08-17 2 bull converging

POC $100.42 · VWAP $99.60 · +24.0% vs 12m avg buyer

uptrend vol: normalgaps: overnight-shiftchurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

INCY Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist INCY belongs to, members best 30-day change first — INCY highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@biotech-scan

Next earnings INCY reports in 70 days Oct 27

Against street estimates

How INCY's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 28 · projection Aug 17

Result
Jul 28 2.153.09+44.0%Beat
Apr 28 1.341.81+35.1%Beat
Feb 10 1.921.80-6.1%Miss
Oct 28 '25 1.642.26+38.0%Beat
Jul 29 '25 1.471.57+6.6%Beat
Apr 29 '25 1.031.16 GAAP ≠ +12.3%Beat
Feb 10 '25 1.551.43-8.0%Miss
Oct 29 '24 1.091.07 GAAP ≠ -2.0%Miss

News (last pull)

Headlines about INCY from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 58 days ago · Jun 21

Types
Jul 28 Catalyst INCY earnings